Simulating the Hallmarks of Cancer
暂无分享,去创建一个
[1] J. Folkman. Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.
[2] R. Rubin. The war on cancer. , 1996, U.S. news & world report.
[3] K Sikora,et al. Developing a global strategy for cancer. , 1999, European journal of cancer.
[4] John S. Lowengrub,et al. A New Ghost Cell/Level Set Method for Moving Boundary Problems: Application to Tumor Growth , 2008, J. Sci. Comput..
[5] Ami Radunskaya,et al. A delay differential equation model for tumor growth , 2003, Journal of mathematical biology.
[6] K. Loeb,et al. Multiple mutations and cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] N. Petrelli,et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[8] James H. Brown,et al. A general model for ontogenetic growth , 2001, Nature.
[9] Memorial Sloan-Kettering,et al. Theoretical Concepts and the Emerging Role of Taxanes in Adjuvant Therapy , 2001 .
[10] M. Sporn. The war on cancer , 1996, The Lancet.
[11] E. Epel,et al. Accelerated telomere shortening in response to life stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] O RAJKA,et al. [TUMOR IMMUNOLOGY]. , 1963, Orvosi hetilap.
[13] Stephanie Forrest,et al. Cancer prevention strategies that address the evolutionary dynamics of neoplastic cells: simulating benign cell boosters and selection for chemosensitivity. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[14] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[15] Paolo Magni,et al. Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents , 2004, Cancer Research.
[16] A. Bouchez,et al. The response of Jupiter's magnetosphere to an outburst on Io. , 1997, Science.
[17] L. Buss,et al. The evolution of individuality , 1987 .
[18] Stephanie Forrest,et al. Exploring the Relationship between Neutral and Selective Mutations in Cancer , 2000, Artificial Life.
[19] J Kuikka. Allometric scaling laws in biology. , 1997, Science.
[20] Evan T Keller,et al. Detection and isolation of circulating tumor cells in urologic cancers: a review. , 2004, Neoplasia.
[21] J. Lowengrub,et al. Nonlinear simulation of the effect of microenvironment on tumor growth. , 2007, Journal of theoretical biology.
[22] S. Spencer,et al. An ordinary differential equation model for the multistep transformation to cancer. , 2004, Journal of theoretical biology.
[23] W. Bodmer,et al. How many mutations in a cancer? , 2002, The American journal of pathology.
[24] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[25] C A Beuchat. Allometric scaling laws in biology. , 1997, Science.
[26] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.
[27] Marina Ziche,et al. Development of new drugs in angiogenesis. , 2004, Current drug targets.
[28] Fariba Behbod,et al. Will cancer stem cells provide new therapeutic targets? , 2005, Carcinogenesis.
[29] A. Prokop,et al. Nanovehicular intracellular delivery systems. , 2008, Journal of pharmaceutical sciences.
[30] M. Blagosklonny,et al. How carcinogens (or telomere dysfunction) induce genetic instability: associated‐selection model , 2001, FEBS letters.
[31] R. Medema,et al. The role of p21ras in receptor tyrosine kinase signaling. , 1993, Critical reviews in oncogenesis.
[32] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[33] David S Wishart,et al. Computational systems biology in drug discovery and development: methods and applications. , 2007, Drug discovery today.
[34] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.